ACRO urges FDA to expedite modernizing clinical trials

04/26/2012 | PharmaTimes (U.K.)

The Association of Clinical Research Organizations asked the FDA to accelerate the modernization of regulations covering U.S. clinical trials. Though there have been some advances in "developing basic building blocks," product development is still expensive, unproductive and slow, ACRO said. The group suggested the FDA hire a chief innovation officer who has the power to authorize new approaches to trials.

View Full Article in:

PharmaTimes (U.K.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC